Josef Gulden
Josef Gulden publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Hematology, on topics such as Lung Cancer Treatments and Mutations, Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research.
- World rank
- #7,702,519 of 7,710,434 ranked researchers
- Rank in Germany
- #363,943 of 364,343
- Works
- 130
- Citations
- 2
What does Josef Gulden research?
Josef Gulden's work is mostly in Medicine (68%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8968.5%
- Medicine8968.5%
- Everything else4131.5%
- 1Pulmonary and Respiratory Medicine18% of their works
- 2Oncology18% of their works
- 3Hematology13% of their works
- 4Genetics8% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Surgery4% of their works
Research topics
Which keywords describe Josef Gulden's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, EGFR Mutations, Targeted Therapy, Acute Myeloid Leukemia, AML, BCR-ABL and Chronic Lymphocytic Leukemia.
- Myelofibrosis
- JAK2 Mutation
- PD-1 and PD-L1
- Lymphoma
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Acute Myeloid Leukemia
- Targeted Therapy
- Rituximab
- Prognostic Factors
- EGFR Mutations
- AML
- BCR-ABL
- Classification
- Imatinib
- Immune Checkpoint Blockade
- CT Screening
- Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors342 topics
- Rituximab322 topics
- EGFR Mutations251 topic
- Targeted Therapy251 topic
- AML181 topic
- Acute Myeloid Leukemia181 topic
- BCR-ABL161 topic
- Chronic Lymphocytic Leukemia161 topic
- Classification161 topic
- Genomic Aberrations161 topic
- Imatinib161 topic
- Lymphoma161 topic
- Immune Checkpoint Blockade121 topic
- PD-1 and PD-L1121 topic
- CT Screening91 topic
- JAK2 Mutation91 topic
- Lung Cancer91 topic
- Myelofibrosis91 topic
Where does Josef Gulden work?
Josef Gulden's main affiliation in the publication record is Technische Hochschule Ulm, Germany.
How many publications and citations does Josef Gulden have?
OpenAlex counts 130 works and 2 citations for Josef Gulden, an h-index of 1, ranking #7,702,519 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Josef Gulden. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.